東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Linked to FindBook

Google Book

Amazon

博客來

Computational intelligence in drug development

Record Type:	Electronic resources : Monograph/item
Title/Author:	Computational intelligence in drug development/ edited by Carlton A. Taft, Sergio Ricardo de Lazaro.
other author:	Taft, Carlton A.
Published:	Cham :Springer Nature Switzerland : : 2025.,
Description:	vi, 168 p. :ill., digital ;24 cm.
[NT 15003449]:	1. Molecular dynamics and prediction of oral toxicity in Alzheimer's disease -- 2. In silico prediction of ADMET parameters, mechanisms of elaboration and performance of computational tools -- 3. Predicting Aloe Vera herb drug interactions -- 4. Enzymes as targets for infectious disease control -- 5. A computational analysis of new strategies against type 2 diabetes mellitus.
Contained By:	Springer Nature eBook
Subject:	Drug development - Data processing. -
Online resource:	https://doi.org/10.1007/978-3-032-07366-2
ISBN:	9783032073662

Computational intelligence in drug development
Computational intelligence in drug development[electronic resource] /edited by Carlton A. Taft, Sergio Ricardo de Lazaro. - Cham :Springer Nature Switzerland :2025. - vi, 168 p. :ill., digital ;24 cm. - Series in bioengineering,2196-887X. - Series in bioengineering..

1. Molecular dynamics and prediction of oral toxicity in Alzheimer's disease -- 2. In silico prediction of ADMET parameters, mechanisms of elaboration and performance of computational tools -- 3. Predicting Aloe Vera herb drug interactions -- 4. Enzymes as targets for infectious disease control -- 5. A computational analysis of new strategies against type 2 diabetes mellitus.

This book offers a comprehensive overview of cutting-edge computational strategies in drug discovery, with a focus on in silico approaches that accelerate the identification and optimization of therapeutic candidates. Readers will find detailed insights into molecular docking, molecular dynamics simulations, and structure-based drug design, alongside predictive models for toxicity, pharmacokinetics (ADMET), and enzyme inhibition. By combining theoretical foundations with practical applications, the volume highlights how artificial intelligence and computational chemistry are reshaping modern pharmaceutical research and enabling the development of safer, more effective drugs.

ISBN: 9783032073662

Standard No.: 10.1007/978-3-032-07366-2doiSubjects--Topical Terms:

1965635
Drug development
--Data processing.

LC Class. No.: RM301.25

Dewey Class. No.: 615.190028563

Computational intelligence in drug development
LDR:02105nmm a22003375a 4500 001 2422260
003 DE-He213
005 20251108120406.0
006 m d
007 cr nn 008maaau
008 260505s2025 sz s 0 eng d
020 $a 9783032073662 $q (electronic bk.)
020 $a 9783032073655 $q (paper)
024 7 $a 10.1007/978-3-032-07366-2 $2 doi
035 $a 978-3-032-07366-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RM301.25
072 7 $a MQW $2 bicssc
072 7 $a TEC059000 $2 bisacsh
072 7 $a MQW $2 thema
082 0 4 $a 615.190028563 $2 23
090 $a RM301.25 $b .C738 2025
245 0 0 $a Computational intelligence in drug development $h [electronic resource] / $c edited by Carlton A. Taft, Sergio Ricardo de Lazaro.
260 $a Cham : $b Springer Nature Switzerland : $b Imprint: Springer, $c 2025.
300 $a vi, 168 p. : $b ill., digital ; $c 24 cm.
490 1 $a Series in bioengineering, $x 2196-887X
505 0 $a 1. Molecular dynamics and prediction of oral toxicity in Alzheimer's disease -- 2. In silico prediction of ADMET parameters, mechanisms of elaboration and performance of computational tools -- 3. Predicting Aloe Vera herb drug interactions -- 4. Enzymes as targets for infectious disease control -- 5. A computational analysis of new strategies against type 2 diabetes mellitus.
520 $a This book offers a comprehensive overview of cutting-edge computational strategies in drug discovery, with a focus on in silico approaches that accelerate the identification and optimization of therapeutic candidates. Readers will find detailed insights into molecular docking, molecular dynamics simulations, and structure-based drug design, alongside predictive models for toxicity, pharmacokinetics (ADMET), and enzyme inhibition. By combining theoretical foundations with practical applications, the volume highlights how artificial intelligence and computational chemistry are reshaping modern pharmaceutical research and enabling the development of safer, more effective drugs.
650 0 $a Drug development $x Data processing. $3 1965635
650 0 $a Computational intelligence. $3 595739
650 1 4 $a Biomedical Engineering and Bioengineering. $3 3381533
650 2 4 $a Computational Intelligence. $3 1001631
700 1 $a Taft, Carlton A. $3 3446307
700 1 $a Lazaro, Sergio Ricardo de. $3 3754001
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a Series in bioengineering. $3 2055868
856 4 0 $u https://doi.org/10.1007/978-3-032-07366-2
950 $a Engineering (SpringerNature-11647)